LINC02159通过ALYREF/YAP1信号传递促进非小细胞肺癌的进展
Qiurong Yang1, Maoye Wang1, Jing Xu1
1Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, 212013, China.
一种新发现的长非编码RNA,LINC02159,通过稳定YAP1 mRNA.促进非小细胞肺癌 (NSCLC) 的进展. 这种lncRNA可以作为NSCLC的诊断标记和治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在癌症发展中的作用和潜在的生物标志物.
- 非小细胞肺癌 (NSCLC) 是最常见的肺癌类型.
研究的目的:
- 确定和描述一种涉及非小细胞肺癌 (NSCLC) 病变的新型长非编码RNA (lncRNA).
- 阐明这种lncRNA调节NSCLC进展的分子机制.
- 评估这个lncRNA作为NSCLC的诊断标记物和治疗点的潜力.
主要方法:
- 转录组分析以确定NSCLC中差异表达的lncRNAs.
- 在体外测试 (细胞增殖,迁移,入侵,细胞亡,细胞循环) 来评估LINC02159.9的功能作用.
- 在体内瘤生长试验评估LINC02159对瘤发展的影响.
- RNA免疫沉 (RIP) 和西方涂抹以调查分子相互作用和信号通路.
- 救援实验以确认对已识别的路径的依赖.
主要成果:
- 发现LINC02159在NSCLC瘤组织和患者血清中被上调.
- 敲除LINC02159抑制NSCLC细胞的增殖,迁移和入侵,同时诱导细胞亡和细胞循环停止.
- 过度表达LINC02159促进了NSCLC的进展.
- LINC02159通过与ALYREF的相互作用来增强YAP1mRNA的稳定性,激活Hippo和β-catenin信号通路.
- LINC02159以依赖于YAP1和ALYREF的方式促进NSCLC的进展.
结论:
- 在NSCLC的进展中,LINC02159作为瘤基因起作用.
- LINC02159/ALYREF/YAP1轴在调节NSCLC细胞行为和瘤生长方面发挥着至关重要的作用.
- LINC02159显示出作为NSCLC的诊断生物标志物和治疗点的潜力.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
相关概念视频
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
lncRNA - Long Non-coding RNAs
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
